Cite

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions : results of a multicenter, single-blind, interindividual, randomized clinical phase III trial

MLA

Wolfgang Brodtrager, et al. Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentate Dimeglumine-Enhanced MRI in 471 Patients with Known or Suspected Renal Lesions : Results of a Multicenter, Single-Blind, Interindividual, Randomized Clinical Phase III Trial. Jan. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a2add241fb60e9ce99568c8faa1a5f2&authtype=sso&custid=ns315887.



APA

Wolfgang Brodtrager, Walter Gross-fengels, Bernd Tombach, Claus D. Claussen, Paul Hajek, Giacomo Gortenuti, Christoph Düber, Eckhardt Grabbe, Ernst J. Rummeny, Małgorzata Szczerbo-Trojanowska, Peter Reimer, Raymond Oyen, Michael Kuhn, Philipp Lengsfeld, Michael Galanski, Roberto Lagalla, Christiane Pering, Andrzej Urbanik, Roberto Pozzi-Mucelli, … Klaus Bohndorf. (2008). Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions : results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.



Chicago

Wolfgang Brodtrager, Walter Gross-fengels, Bernd Tombach, Claus D. Claussen, Paul Hajek, Giacomo Gortenuti, Christoph Düber, et al. 2008. “Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentate Dimeglumine-Enhanced MRI in 471 Patients with Known or Suspected Renal Lesions : Results of a Multicenter, Single-Blind, Interindividual, Randomized Clinical Phase III Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a2add241fb60e9ce99568c8faa1a5f2&authtype=sso&custid=ns315887.